Neuralink's Claim - Successful Second Trial of Brain Chip Implantation in Humans

Kathmandu. Elon Musk's Neuralink has been working on developing brain chips for patients with paralysis. The company has announced the successful second trial in this regard.

Neuralink has developed wireless chips that will allow physically disabled patients to function normally.

Musk's brain technology startup Neuralink claims to have successfully completed the second trial of implanting a chip into the human brain. The company states that the patient did not experience any issues during the second trial. In the first trial, a problem of thread retraction was observed in the patient who received the brain chip implant.

Neuralink has been working for years to develop brain chips for patients with paralysis or individuals with spinal cord injuries. During the first trial, patient Noland Arbog, who had the chip implanted in his brain by Neuralink in January, developed a thread retraction issue shortly after. After the surgery, many of the tiny fibers in Arbog's brain showed signs of constriction, reducing the number of electrodes measuring brain signals.

After the chip implantation, the patient's condition improved. According to media reports, the issue of thread retraction was also noted during tests on animals. Now the company claims that such a problem did not occur in the second trial.

Reports mention that the first patient who underwent digital chip implantation by Neuralink is now able to play video games, access the internet, post on social media, etc. Just last month, another patient was tested with a chip.

Neuralink is a brain-chip startup founded by Elon Musk in 2016. Under this startup, a coin-sized device (chip) has been implanted in the human brain with the help of surgery. Its very thin wires go into the brain and develop a brain-computer interface. This disk records brain activity and sends it to devices like smartphones via a regular Bluetooth connection.